A Study of the Concentration of Mesenchymal Stem Cells in the Joint Fluid of the Hip in Patients who have Bone Necrosis

Overview

About this study

The purpose of this study is to determine if the concentration of mesenchymal stem cells in the joint fluid of the hip increases to compare with the severity of the disease in patients with osteonecrosis ( bone decay) of the femoral head (leg bone/hip joint).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

Consented to undergo a THA (post-collapse osteonecrosis), hip arthroscopy or minimally invasive core decompression
Preoperative radiographic diagnosis of ON or FAI (femoral/acetabular impingement)

Exclusion Criteria

Pregnant
Active infection, HIV, Hepatitis C or B, syphilis Immunodeficiency
Is receiving hematopoetic growth factors or anti-angiogenesis products

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Rafael Sierra, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Rafael Sierra, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials